Zenotech Laboratories Limited Share Price

Equities

ZENOTECH6

INE486F01012

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:55 26/04/2024 BST 5-day change 1st Jan Change
69.56 INR +1.44% Intraday chart for Zenotech Laboratories Limited +8.42% +4.48%

Financials

Sales 2022 329M 3.95M 316M Sales 2023 390M 4.68M 374M Capitalization 2.87B 34.46M 2.75B
Net income 2022 222M 2.66M 213M Net income 2023 116M 1.39M 111M EV / Sales 2022 9.44 x
Net Debt 2022 35.85M 430K 34.36M Net cash position 2023 111M 1.34M 107M EV / Sales 2023 7.08 x
P/E ratio 2022
13.9 x
P/E ratio 2023
24.8 x
Employees 150
Yield 2022 *
-
Yield 2023
-
Free-Float 15.21%
More Fundamentals * Assessed data
Dynamic Chart
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Sun Pharmaceutical Acquires More Stake in Zenotech Laboratories MT
Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
Zenotech Laboratories : Appoints New CEO MT
Zenotech Laboratories Limited Appoints Devendra Chandrakant S. Kenkre as Chief Executive Officer CI
More news
1 day+1.44%
1 week+8.42%
Current month+17.68%
1 month+17.68%
3 months-3.87%
6 months+3.30%
Current year+4.48%
More quotes
1 week
66.00
Extreme 66
71.39
1 month
60.00
Extreme 60
74.65
Current year
55.86
Extreme 55.86
81.00
1 year
49.60
Extreme 49.6
81.00
3 years
38.00
Extreme 38
81.00
5 years
12.00
Extreme 12
81.00
10 years
12.00
Extreme 12
81.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22/01/21
Director of Finance/CFO - 05/02/14
Compliance Officer - 10/03/16
Members of the board TitleAgeSince
Director/Board Member 56 31/03/15
Director/Board Member 56 07/07/15
Chairman 65 24/08/15
More insiders
Date Price Change Volume
26/04/24 69.56 +1.44% 31,678
25/04/24 68.57 -0.31% 11,008
24/04/24 68.78 +0.32% 9,374
23/04/24 68.56 +3.47% 17,902
22/04/24 66.26 +3.27% 13,786

Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am

More quotes
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. ZENOTECH6 Stock